BMO Capital analyst Sean Dodge initiated coverage of TruBridge (TBRG) with a Market Perform rating and $19.50 price target The firm believes the company’s realignment around revenue cycle management provides a more attractive growth opportunity versus the clinical software space. BMO expects to get positive on the shares as evidence of the company’s traction becomes more apparent.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TBRG:
- TruBridge, Inc. Earnings Call: Mixed Sentiments and Optimistic Outlook
- TruBridge, Inc. Reports Strong Q3 2025 Performance
- TruBridge reports Q3 adjusted EPS 88c, consensus 47c
- TruBridge sees Q4 revenue $86M-$89M, consensus $88.78M
- TruBridge narrows FY25 revenue viewe to $345M-$348M, consensus $347.27M